PARIS, July 27, 2023 /PRNewswire/ -- EKINOPS (Euronext Paris – FR0011466069 – EKI), a leading supplier of telecommunications solutions for telecom operators and enterprises, reports its H1 2023 financial statements (for the period ended 30 June 2023) as approved by the Board of Directors on 26 July 2023. The statutory auditors conducted an interim review of these half-year financial statements.
m€ - IFRS |
H1 2022 |
H1 2023 |
Change |
Revenue |
63.3 |
71.0 |
+12 % |
Gross margin |
33.5 |
37.7 |
+13 % |
% of revenue |
52.9 % |
53.1 % |
|
Operating expenses |
29.3 |
31.0 |
+6 % |
EBITDA1 |
10.8 |
14.3 |
+33 % |
% of revenue |
17.0 % |
20.2 % |
|
Current operating income |
4.1 |
6.7 |
+61 % |
Operating income/(loss) |
4.2 |
6.6 |
+60 % |
Consolidated net income/(loss) |
5.2 |
6.0 |
+15 % |
% of revenue |
8.2 % |
8.4 % |
1 EBITDA (Earnings before interest, taxes, depreciation, and amortization) corresponds to current operating income restated for (i) amortization, depreciation and provisions and (ii) income and expenses linked to share-based payments (see appendices)
H1 2023 revenue: 71.0m€, up 12%
Ekinops recorded H1 2023 consolidated revenue of €71.0m, up a solid +12% despite very challenging basis for comparison, with +25% growth posted in H1 2022. At constant exchange rates, half-year growth was also +12%.
Growth was driven primarily by the +41% jump in Optical Transport equipment sales over the period, enabled by the success of WDM solutions and the appeal of OTN technology in the US and Europe. Access solutions sales fell by -5% over H1 2023 (vs. +21% a year earlier), mainly due to lower sales in Asia-Pacific, but remained virtually stable in France and grew by +7% in EMEA. Software & Services business accounted for 14% of the Group's total revenues.
Geographically, first-half revenue rose sharply by +42% in North America (identical in USD terms), which now accounts for 26% of Ekinops' business. The EMEA region, which accounts for 39% of the Group's sales, posted growth of +13% at mid-year. Revenue in Asia-Pacific was down -65%, following +80% growth in the H1 2022. Lastly, in France, where the Group generated 34% of its H1 revenue, sales volumes were up +9% vs. H1 2022.
Record high EBITDA1 margin of 20.2%
H1 2023 gross margin stood at 37.7m€, up +13% Y-o-Y, despite a complex economic environment and heightened market competitiveness. Gross margin thus represented 53.1% of consolidated revenue in H1 2023 vs. 52.9% a year earlier and 53.0% end-2022.
At mid-year, EBITDA came to 14.3m€, vs. 10.8m€ a year earlier, representing sustained growth of +33%. The rise in operating expenses was very well controlled (modest increase of +6% below the pace of revenue growth), despite the investments necessary to accompany the Group's expansion and growth (net rise in headcount of +37 over the last 6 months, R&D equipment purchases and higher number of exhibitions and business travel).
As such, H1 2023 EBITDA margin reached a record level of 20.2%, exceeding the 20% mark for the first time. EBITDA margin was 17.7% in 2022 and 16.9% in 2021.
Adjusted EBIT of 14% in H1 2023
After accounting for net depreciation, amortization and provisions (7.1m€, including 3.2m€ of amortization relating to post purchase price allocation technologies) and non-cash expenses relating to share-based payments (0.7m€), current operating income came to 6.7m€ in H1 2023, up a strong +61% on the same period last year. Current operating margin therefore represents 9.4% of revenue vs. 6.5% in the year-earlier period. Excluding amortization of intangible assets identified post purchase price allocation, adjusted EBIT2 came to 14.0%, compared with 11.2% a year earlier.
In the absence of other significant operating income and expenses, operating income rose by +60% to 6.6m€ in H1 2023, compared with 4.2m€ a year earlier.
After taking into account financial expenses of 0.1m€ and a tax expense of 0.5m€, H1 2023 net income rose by 15% to 6m€, vs. 5.2m€ in H1 2022.
Net margin for the semester was 8.4%, vs. 8.2% a year earlier.
Net cash3 of 20.3m€ as of 30 June 2023
The positive trend in Ekinops' operating indicators led to a +36% increase in cash flow, to 14.6m€.
The increase in working capital requirements to +13.1m€ was mainly due to buoyant business at the end of H1 (+10.2m€ increase in accounts receivable). Operating cash flow therefore amounted to 0.9m€, vs. 2.2m€ in H1 2022.
Cash flow from investments (non-current assets and R&D) amounted to a 4.4m€ outflow (vs. 2.8m€ in H1 2022) with 2.4m€ in equipment investments and 2.0m€ for capitalized R&D.
Cash flow from financing activities totaled +11.7m€, including +10.6m€ in new bank loans contracted net of reimbursements over the period. This also included the 7.8m€ participatory recovery loan (Prêt Participatif de Relance - PPR), which was cashed at the beginning of March 2023.
Cash and cash equivalents totaled 47.6m€ as of 30 June 2023 (vs. 39.4m€ a year earlier), for financial borrowings4 of 27.3m€.
As such, Ekinops had a very solid financial position at the end of H1 2023 with net cash at 20.3m€ (vs. 19.3m€ a year earlier and €20.5m at end-2022), and equity of €121.1m (up +7.5m€ from end-December 2022).
At the close of the half-year period, Ekinops arranged a new 100m€ financing line with its banking partners, to provide the company with additional financial resources to support its development, in particular its acquisitions strategy, using non-dilutive financing methods5. The new financing consists of a confirmed 50m€ external growth loan (which may be increased to 90m€ under certain conditions) with a seven-year maturity, and a revolving loan of up to 10m€. These new financings will benefit from ESG targets that take into account Ekinops' Corporate Social Responsibility (CSR) strategy.
ASSETS - €m |
12/31 2022 |
06/30 2023 |
LIABILITIES - €m |
12/31 2022 |
06/30 2023 |
|
Non-current assets |
79.8 |
77.8 |
Shareholders' equity |
113.6 |
121.1 |
|
o/w goodwill |
28.5 |
28.5 |
Financial liabilities |
18.9 |
27.3 |
|
o/w intangible assets |
21.1 |
19.1 |
o/w bank loans |
14.5 |
20.7 |
|
o/w right-of-use assets |
6.8 |
7.8 |
o/w factoring |
4.4 |
6.6 |
|
Current assets |
63.5 |
77.2 |
French research tax |
2.6 |
6.8 |
|
o/w inventories |
25.0 |
24.9 |
Trade payables |
17.7 |
16.5 |
|
o/w trade receivables |
29.9 |
40.0 |
Lease liabilities |
6.9 |
8.0 |
|
Cash & cash equivalents |
39.4 |
47.6 |
Other liabilities |
23.0 |
22.9 |
|
TOTAL |
182.7 |
202.6 |
TOTAL |
182.7 |
202.6 |
Outlook
The H1 2023 figures testify to a very good performance by Ekinops, with solid double-digit growth, despite a very demanding base effect, and record profitability, with EBITDA margin over 20% for the first time, and adjusted EBIT of 14.0%.
In today's less buoyant market environment, with less visibility for H2 2023, Ekinops' priority is to intensify its hunting of new customers in all its geographies.
At mid-year, 2023 financial targets remain unchanged:
- revenue growth of over +12%, with a return to a more traditional seasonal pattern in H2;
- EBITDA margin between 15% and 19%.
In terms of external growth, Ekinops maintains its ambition to complete a transaction during the year, favoring a non-dilutive source of financing.
For more information, please refer to www.ekinops.com
All press releases are published after the close of trading on Euronext Paris.
EKINOPS Contact
Didier Brédy
Chairman and CEO
[email protected]
Investors
Mathieu Omnes
Investor relation
Tel.: +33 (0)1 53 67 36 92
[email protected]
Press
Amaury Dugast
Press relation
Tel.: +33 (0)1 53 67 36 74
[email protected]
[1] EBITDA (Earnings before interest, taxes, depreciation, and amortization) corresponds to current operating income restated for (i) amortization, depreciation and provisions and (ii) income and expenses linked to share-based payments (see appendices).
[2] Adjusted EBIT corresponds to current operating income adjusted for amortization charges related to intangible assets identified post purchase price allocation, i.e. developed technologies and customer relation.
[3] Net cash = cash and cash equivalents – borrowings (excluding bank debt relating to R&D tax credit (CIR) pre-financing and IFRS 16 lease liabilities).
[4] Financial debt excluding bank debt relating to R&D tax credit pre-financing and IFRS 16 lease liabilities.
[5] See press release of 19 July 2023
Photo - https://mma.prnewswire.com/media/2164138/Ekinops_H1_2023.jpg
Logo - https://mma.prnewswire.com/media/814911/Ekinops_Logo.jpg
SOURCE Ekinops
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article